CAS: 29070-92-6; Pachymic Acid

该化合物是一种主要来自Poria cocos(传统医学中广泛使用的一种药用真菌)的三肢类化合物,它展示了显著的生物活动,包括抗炎,抗菌和免疫细胞效应.其结构特征是其薄膜型骨骼,对帕希米亚酸进行了研究,研究其潜在作用是抑制NF-XXB信号路径,这在炎症和癌症的不断演变中起着作用.它的疏水性和稳定性使它适合于药物学研究,特别是针对慢性炎症和某些癌症的药物研制.HPLC和LC-MS等分析方法通常用于隔离和量化,确保研究应用的高纯度.

结构式图片

合成工艺路线路线简述

    📜Pachymic Acid Phthalimidomethyl Ester置于sodium Hydroxide体系中,用 乙醇,氯仿 用作溶剂,以20 Mg的收率获得茯苓酸
    参考文献:从茯苓菌核中分离出具有乙酰氧基的羊毛甾烷型三萜酸
    标题:从茯苓菌核中分离出具有乙酰氧基的羊毛甾烷型三萜酸
    摘要:摘要 通过邻苯二甲酰亚胺甲酯的制备型高效液相色谱法以及邻苯二甲酰亚胺甲酯基团的选择性水解,有效地从茯苓菌核中分离出带有乙酰氧基的羊毛甾烷型三萜酸.通过这种方法,分离出三种新的三萜酸,以及作为hoelen特征化合物的厚皮酸和脱氢厚皮酸.根据光谱证据,确定了三种新化合物的结构分别为 3-O-乙酰基-16α-羟基脱氢曲美烯酸和 3-表皮氢重甲酸.
    Doi:10.1016/0031-9422(95)00182-7

    海关参考信息

    专利信息


    专利号:US-9321804-B2
    优先权日:2011-03-09
    标题 :Synthesis and use of anti-tumor drug LQC-Y
    发明人:LEI HAIMIN
    权利人:UNIV BEIJING CHINESE MEDICINE; 3D MEDICINES LTD
    摘要:Disclosed are the general structural formula of LQC-Y as well as the synthesis and use thereof. Pharmacological experiments demonstrated the marked antitumor effect of such compounds. Single day administration of LQC-Y3 to mice at a maximum dose of 6000 mg/kg showed no toxicity response during the 14-day continuous observation period, indicating the high safety of the compounds, and the compounds can be used to prepare medicaments for preventing and treating carcinomas such as liver cancer, lung cancer. In the general structural formula of LQC-Y, R represents steroid compounds such as cholic acid, deoxycholic acid, ursodeoxycholic acid, chenodeoxycholic acid, and hyodeoxycholic acid and so on; triterpenoid compounds such as oleanolic acid, ursolic acid, pachymic acid, glycyrrhetinic acid and glycosides thereof and so on; emodic acid, emodin and other mono-substituted or poly-substituted structures of anthraquinone parent nucleus; baicalein, baicalin and other flavonoid; shikimic acid, mono-substituted shikimic acid or poly-substituted shikimic acid; gardenia acid and other iridoid acid derivatives; paeonol, curcumin and structural derivatives thereof.

    专利号:US-2014011786-A1
    优先权日:2011-03-09
    标题:Synthesis and use of anti-tumor drug lqc-y

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Xu X, Wang J, Jin X, Ma Q, Li H, Zhou Q, Chen W. Bu-Shen-Ning-Xin decoction ameliorates premature ovarian insufficiency by suppressing oxidative stress through rno_circRNA_012284/rno_miR-760-3p/HBEGF pathway. Phytomedicine. 2024 Jul 29;133:155920. doi: 10.1016/j.phymed.2024.155920. Epub ahead of print. 77(6):ovae054. doi: 10.1093/lambio/ovae054. 7(1):666. doi: 10.1038/s42003-024-06323-1.
    4: Li X, He A, Liu C, Li Y, Luo Y, Xiong W, Nian W, Zuo D. Pachymic acid activates TP53INP2/TRAF6/caspase-8 pathway to promote apoptosis in renal cell carcinoma cells. Environ Toxicol. 2024 Apr 1. doi: 10.1002/tox.24195. Epub ahead of print. 24(1):352. doi: 10.1186/s12903-024-04108-w.
    6: Wu T, Hou W, Li S, Liu C, Zhang Y. Integrated analysis and separation of 5-lipoxygenase inhibitors from triterpenes of Poria cocos using bioaffinity ultrafiltration UPLC-Q-Exactive, molecular docking and target-based multiple complex networks. Fitoterapia. 2024 Jun;175:105856. doi: 10.1016/j.fitote.2024.105856. Epub 2024 Feb 12.

    合成参考文献


    参考文献:10.1248/cpb.6.608
    摘要:Shibata S, Natori S, Fujita K, Kitagawa I, Watanabe K. Metabolic Products of Fungi. XV. Pachymic Acid, a Constituent of"Bukuryo"(Fu Ling ), a Sclerotium of Poria cocos (SCHW.) WOLF. Chem. Pharm. Bull. 1958;6(6):608–11. doi: 10.1248/cpb.6.608.
    参考文献:10.1071/ch9710609
    摘要:Pinhey J, Ralph B, Simes J, Wootton M. Extractives of fungi. II. The constituents of Trametes feei . 6α-Hydroxypolyporenic acid C. 1971 Mar 01;24(3):609–19. doi: 10.1071/ch9710609.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知